The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Long Acting Insulins Market Research Report 2025
Synopsis
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
The global Long Acting Insulins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Long Acting Insulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long Acting Insulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Long Acting Insulins in Home Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Long Acting Insulins include Novo Nordisk, Sanofi and Wockhardt UK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Long Acting Insulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Acting Insulins.
Report Scope
The Long Acting Insulins market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long Acting Insulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long Acting Insulins companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Wockhardt UK
Segment by Type
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Segment by Application
Home Use
Medical Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Acting Insulins companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
The global Long Acting Insulins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Long Acting Insulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long Acting Insulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Long Acting Insulins in Home Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Long Acting Insulins include Novo Nordisk, Sanofi and Wockhardt UK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Long Acting Insulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Acting Insulins.
Report Scope
The Long Acting Insulins market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long Acting Insulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long Acting Insulins companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Wockhardt UK
Segment by Type
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Segment by Application
Home Use
Medical Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Acting Insulins companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Insulin Glargine
1.2.3 Insulin Determir
1.2.4 Insulin Degludec
1.2.5 Long Acting Animal Insulin
1.3 Market by Application
1.3.1 Global Long Acting Insulins Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Insulins Market Perspective (2019-2030)
2.2 Long Acting Insulins Growth Trends by Region
2.2.1 Global Long Acting Insulins Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Long Acting Insulins Historic Market Size by Region (2019-2024)
2.2.3 Long Acting Insulins Forecasted Market Size by Region (2025-2030)
2.3 Long Acting Insulins Market Dynamics
2.3.1 Long Acting Insulins Industry Trends
2.3.2 Long Acting Insulins Market Drivers
2.3.3 Long Acting Insulins Market Challenges
2.3.4 Long Acting Insulins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Insulins Players by Revenue
3.1.1 Global Top Long Acting Insulins Players by Revenue (2019-2024)
3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2019-2024)
3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Insulins Revenue
3.4 Global Long Acting Insulins Market Concentration Ratio
3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2023
3.5 Long Acting Insulins Key Players Head office and Area Served
3.6 Key Players Long Acting Insulins Product Solution and Service
3.7 Date of Enter into Long Acting Insulins Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Insulins Breakdown Data by Type
4.1 Global Long Acting Insulins Historic Market Size by Type (2019-2024)
4.2 Global Long Acting Insulins Forecasted Market Size by Type (2025-2030)
5 Long Acting Insulins Breakdown Data by Application
5.1 Global Long Acting Insulins Historic Market Size by Application (2019-2024)
5.2 Global Long Acting Insulins Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Long Acting Insulins Market Size (2019-2030)
6.2 North America Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Long Acting Insulins Market Size by Country (2019-2024)
6.4 North America Long Acting Insulins Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long Acting Insulins Market Size (2019-2030)
7.2 Europe Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Long Acting Insulins Market Size by Country (2019-2024)
7.4 Europe Long Acting Insulins Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Insulins Market Size (2019-2030)
8.2 Asia-Pacific Long Acting Insulins Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Long Acting Insulins Market Size by Region (2019-2024)
8.4 Asia-Pacific Long Acting Insulins Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long Acting Insulins Market Size (2019-2030)
9.2 Latin America Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Long Acting Insulins Market Size by Country (2019-2024)
9.4 Latin America Long Acting Insulins Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Insulins Market Size (2019-2030)
10.2 Middle East & Africa Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Long Acting Insulins Market Size by Country (2019-2024)
10.4 Middle East & Africa Long Acting Insulins Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Long Acting Insulins Introduction
11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2019-2024)
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Long Acting Insulins Introduction
11.2.4 Sanofi Revenue in Long Acting Insulins Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Wockhardt UK
11.3.1 Wockhardt UK Company Detail
11.3.2 Wockhardt UK Business Overview
11.3.3 Wockhardt UK Long Acting Insulins Introduction
11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2019-2024)
11.3.5 Wockhardt UK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Insulin Glargine
Table 3. Key Players of Insulin Determir
Table 4. Key Players of Insulin Degludec
Table 5. Key Players of Long Acting Animal Insulin
Table 6. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Long Acting Insulins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Long Acting Insulins Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Long Acting Insulins Market Share by Region (2019-2024)
Table 10. Global Long Acting Insulins Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Long Acting Insulins Market Share by Region (2025-2030)
Table 12. Long Acting Insulins Market Trends
Table 13. Long Acting Insulins Market Drivers
Table 14. Long Acting Insulins Market Challenges
Table 15. Long Acting Insulins Market Restraints
Table 16. Global Long Acting Insulins Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Long Acting Insulins Market Share by Players (2019-2024)
Table 18. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2023)
Table 19. Ranking of Global Top Long Acting Insulins Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Long Acting Insulins Product Solution and Service
Table 23. Date of Enter into Long Acting Insulins Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Long Acting Insulins Revenue Market Share by Type (2019-2024)
Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Long Acting Insulins Revenue Market Share by Type (2025-2030)
Table 29. Global Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Long Acting Insulins Revenue Market Share by Application (2019-2024)
Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Long Acting Insulins Revenue Market Share by Application (2025-2030)
Table 33. North America Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Long Acting Insulins Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Long Acting Insulins Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Long Acting Insulins Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)
Table 48. Novo Nordisk Company Detail
Table 49. Novo Nordisk Business Overview
Table 50. Novo Nordisk Long Acting Insulins Product
Table 51. Novo Nordisk Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)
Table 52. Novo Nordisk Recent Development
Table 53. Sanofi Company Detail
Table 54. Sanofi Business Overview
Table 55. Sanofi Long Acting Insulins Product
Table 56. Sanofi Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. Wockhardt UK Company Detail
Table 59. Wockhardt UK Business Overview
Table 60. Wockhardt UK Long Acting Insulins Product
Table 61. Wockhardt UK Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)
Table 62. Wockhardt UK Recent Development
Table 63. Research Programs/Design for This Report
Table 64. Key Data Information from Secondary Sources
Table 65. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Insulins Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Long Acting Insulins Market Share by Type: 2023 VS 2030
Figure 3. Insulin Glargine Features
Figure 4. Insulin Determir Features
Figure 5. Insulin Degludec Features
Figure 6. Long Acting Animal Insulin Features
Figure 7. Global Long Acting Insulins Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Long Acting Insulins Market Share by Application: 2023 VS 2030
Figure 9. Home Use Case Studies
Figure 10. Medical Institutions Case Studies
Figure 11. Others Case Studies
Figure 12. Long Acting Insulins Report Years Considered
Figure 13. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Long Acting Insulins Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Long Acting Insulins Market Share by Region: 2023 VS 2030
Figure 16. Global Long Acting Insulins Market Share by Players in 2023
Figure 17. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2023
Figure 19. North America Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Long Acting Insulins Market Share by Country (2019-2030)
Figure 21. United States Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Long Acting Insulins Market Share by Country (2019-2030)
Figure 25. Germany Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Long Acting Insulins Market Share by Region (2019-2030)
Figure 33. China Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Long Acting Insulins Market Share by Country (2019-2030)
Figure 41. Mexico Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Long Acting Insulins Market Share by Country (2019-2030)
Figure 45. Turkey Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2019-2024)
Figure 48. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2019-2024)
Figure 49. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
